Cargando…
Multisystem inflammatory syndrome in children and SARS-CoV-2 variants: a two-year ambispective multicentric cohort study in Catalonia, Spain
Multisystem inflammatory syndrome in children (MIS-C) is a rare but severe disease temporarily related to SARS-CoV-2. We aimed to describe the epidemiological, clinical, and laboratory findings of all MIS-C cases diagnosed in children < 18 years old in Catalonia (Spain) to study their trend throu...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9937862/ https://www.ncbi.nlm.nih.gov/pubmed/36801975 http://dx.doi.org/10.1007/s00431-023-04862-z |
_version_ | 1784890518343254016 |
---|---|
author | Pino, Rosa Antoñanzas, Jesús M. Paredes-Carmona, Fernando Perramon, Aida Rivière, Jacques G. Coma, Maria Martínez-Mejías, Abel Ripoll, Francesc López, Núria Conti, Romina Sala-Castellví, Pere Ruiz, Montserrat Brio, Sonia García-Lorenzo, Marc Esteller, Maria Carreras-Abad, Clara Herrero-Hernando, Carlos Schneider, Stephan Otto Gatell, Anna Aguilar, Isabel Cantero, Javier Ruiz, Gloria Fenollosa, Teresa Lobato, Zulema Villalobos, Pilar Mora, Emiliano Anton, Jordi Visa-Reñé, Núria Soler-Palacin, Pere Calavia, Olga Esquirol-Herrero, Cristina Guarch-Ibañez, Borja García-García, Juan-José Coma, Ermengol Fina, Francesc Prats, Clara Soriano-Arandes, Antoni |
author_facet | Pino, Rosa Antoñanzas, Jesús M. Paredes-Carmona, Fernando Perramon, Aida Rivière, Jacques G. Coma, Maria Martínez-Mejías, Abel Ripoll, Francesc López, Núria Conti, Romina Sala-Castellví, Pere Ruiz, Montserrat Brio, Sonia García-Lorenzo, Marc Esteller, Maria Carreras-Abad, Clara Herrero-Hernando, Carlos Schneider, Stephan Otto Gatell, Anna Aguilar, Isabel Cantero, Javier Ruiz, Gloria Fenollosa, Teresa Lobato, Zulema Villalobos, Pilar Mora, Emiliano Anton, Jordi Visa-Reñé, Núria Soler-Palacin, Pere Calavia, Olga Esquirol-Herrero, Cristina Guarch-Ibañez, Borja García-García, Juan-José Coma, Ermengol Fina, Francesc Prats, Clara Soriano-Arandes, Antoni |
author_sort | Pino, Rosa |
collection | PubMed |
description | Multisystem inflammatory syndrome in children (MIS-C) is a rare but severe disease temporarily related to SARS-CoV-2. We aimed to describe the epidemiological, clinical, and laboratory findings of all MIS-C cases diagnosed in children < 18 years old in Catalonia (Spain) to study their trend throughout the pandemic. This was a multicenter ambispective observational cohort study (April 2020–April 2022). Data were obtained from the COVID-19 Catalan surveillance system and from all hospitals in Catalonia. We analyzed MIS-C cases regarding SARS-CoV-2 variants for demographics, symptoms, severity, monthly MIS-C incidence, ratio between MIS-C and accumulated COVID-19 cases, and associated rate ratios (RR). Among 555,848 SARS-CoV-2 infections, 152 children were diagnosed with MIS-C. The monthly MIS-C incidence was 4.1 (95% CI: 3.4–4.8) per 1,000,000 people, and 273 (95% CI: 230–316) per 1,000,000 SARS-CoV-2 infections (i.e., one case per 3,700 SARS-CoV-2 infections). During the Omicron period, the MIS-C RR was 8.2 (95% CI: 5.7–11.7) per 1,000,000 SARS-CoV-2 infections, which was significantly lower (p < 0.001) than that for previous variant periods in all age groups. The median [IQR] age of MIS-C was 8 [4–11] years, 62.5% male, and 80.2% without comorbidities. Common symptoms were gastrointestinal findings (88.2%) and fever > 39 °C (81.6%); nearly 40% had an abnormal echocardiography, and 7% had coronary aneurysm. Clinical manifestations and laboratory data were not different throughout the variant periods (p > 0.05). Conclusion: The RR between MIS-C cases and SARS-CoV-2 infections was significantly lower in the Omicron period for all age groups, including those not vaccinated, suggesting that the variant could be the main factor for this shift in the MISC trend. Regardless of variant type, the patients had similar phenotypes and severity throughout the pandemic. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00431-023-04862-z. |
format | Online Article Text |
id | pubmed-9937862 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-99378622023-02-21 Multisystem inflammatory syndrome in children and SARS-CoV-2 variants: a two-year ambispective multicentric cohort study in Catalonia, Spain Pino, Rosa Antoñanzas, Jesús M. Paredes-Carmona, Fernando Perramon, Aida Rivière, Jacques G. Coma, Maria Martínez-Mejías, Abel Ripoll, Francesc López, Núria Conti, Romina Sala-Castellví, Pere Ruiz, Montserrat Brio, Sonia García-Lorenzo, Marc Esteller, Maria Carreras-Abad, Clara Herrero-Hernando, Carlos Schneider, Stephan Otto Gatell, Anna Aguilar, Isabel Cantero, Javier Ruiz, Gloria Fenollosa, Teresa Lobato, Zulema Villalobos, Pilar Mora, Emiliano Anton, Jordi Visa-Reñé, Núria Soler-Palacin, Pere Calavia, Olga Esquirol-Herrero, Cristina Guarch-Ibañez, Borja García-García, Juan-José Coma, Ermengol Fina, Francesc Prats, Clara Soriano-Arandes, Antoni Eur J Pediatr Research Multisystem inflammatory syndrome in children (MIS-C) is a rare but severe disease temporarily related to SARS-CoV-2. We aimed to describe the epidemiological, clinical, and laboratory findings of all MIS-C cases diagnosed in children < 18 years old in Catalonia (Spain) to study their trend throughout the pandemic. This was a multicenter ambispective observational cohort study (April 2020–April 2022). Data were obtained from the COVID-19 Catalan surveillance system and from all hospitals in Catalonia. We analyzed MIS-C cases regarding SARS-CoV-2 variants for demographics, symptoms, severity, monthly MIS-C incidence, ratio between MIS-C and accumulated COVID-19 cases, and associated rate ratios (RR). Among 555,848 SARS-CoV-2 infections, 152 children were diagnosed with MIS-C. The monthly MIS-C incidence was 4.1 (95% CI: 3.4–4.8) per 1,000,000 people, and 273 (95% CI: 230–316) per 1,000,000 SARS-CoV-2 infections (i.e., one case per 3,700 SARS-CoV-2 infections). During the Omicron period, the MIS-C RR was 8.2 (95% CI: 5.7–11.7) per 1,000,000 SARS-CoV-2 infections, which was significantly lower (p < 0.001) than that for previous variant periods in all age groups. The median [IQR] age of MIS-C was 8 [4–11] years, 62.5% male, and 80.2% without comorbidities. Common symptoms were gastrointestinal findings (88.2%) and fever > 39 °C (81.6%); nearly 40% had an abnormal echocardiography, and 7% had coronary aneurysm. Clinical manifestations and laboratory data were not different throughout the variant periods (p > 0.05). Conclusion: The RR between MIS-C cases and SARS-CoV-2 infections was significantly lower in the Omicron period for all age groups, including those not vaccinated, suggesting that the variant could be the main factor for this shift in the MISC trend. Regardless of variant type, the patients had similar phenotypes and severity throughout the pandemic. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00431-023-04862-z. Springer Berlin Heidelberg 2023-02-18 2023 /pmc/articles/PMC9937862/ /pubmed/36801975 http://dx.doi.org/10.1007/s00431-023-04862-z Text en © The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2023, Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Research Pino, Rosa Antoñanzas, Jesús M. Paredes-Carmona, Fernando Perramon, Aida Rivière, Jacques G. Coma, Maria Martínez-Mejías, Abel Ripoll, Francesc López, Núria Conti, Romina Sala-Castellví, Pere Ruiz, Montserrat Brio, Sonia García-Lorenzo, Marc Esteller, Maria Carreras-Abad, Clara Herrero-Hernando, Carlos Schneider, Stephan Otto Gatell, Anna Aguilar, Isabel Cantero, Javier Ruiz, Gloria Fenollosa, Teresa Lobato, Zulema Villalobos, Pilar Mora, Emiliano Anton, Jordi Visa-Reñé, Núria Soler-Palacin, Pere Calavia, Olga Esquirol-Herrero, Cristina Guarch-Ibañez, Borja García-García, Juan-José Coma, Ermengol Fina, Francesc Prats, Clara Soriano-Arandes, Antoni Multisystem inflammatory syndrome in children and SARS-CoV-2 variants: a two-year ambispective multicentric cohort study in Catalonia, Spain |
title | Multisystem inflammatory syndrome in children and SARS-CoV-2 variants: a two-year ambispective multicentric cohort study in Catalonia, Spain |
title_full | Multisystem inflammatory syndrome in children and SARS-CoV-2 variants: a two-year ambispective multicentric cohort study in Catalonia, Spain |
title_fullStr | Multisystem inflammatory syndrome in children and SARS-CoV-2 variants: a two-year ambispective multicentric cohort study in Catalonia, Spain |
title_full_unstemmed | Multisystem inflammatory syndrome in children and SARS-CoV-2 variants: a two-year ambispective multicentric cohort study in Catalonia, Spain |
title_short | Multisystem inflammatory syndrome in children and SARS-CoV-2 variants: a two-year ambispective multicentric cohort study in Catalonia, Spain |
title_sort | multisystem inflammatory syndrome in children and sars-cov-2 variants: a two-year ambispective multicentric cohort study in catalonia, spain |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9937862/ https://www.ncbi.nlm.nih.gov/pubmed/36801975 http://dx.doi.org/10.1007/s00431-023-04862-z |
work_keys_str_mv | AT pinorosa multisysteminflammatorysyndromeinchildrenandsarscov2variantsatwoyearambispectivemulticentriccohortstudyincataloniaspain AT antonanzasjesusm multisysteminflammatorysyndromeinchildrenandsarscov2variantsatwoyearambispectivemulticentriccohortstudyincataloniaspain AT paredescarmonafernando multisysteminflammatorysyndromeinchildrenandsarscov2variantsatwoyearambispectivemulticentriccohortstudyincataloniaspain AT perramonaida multisysteminflammatorysyndromeinchildrenandsarscov2variantsatwoyearambispectivemulticentriccohortstudyincataloniaspain AT rivierejacquesg multisysteminflammatorysyndromeinchildrenandsarscov2variantsatwoyearambispectivemulticentriccohortstudyincataloniaspain AT comamaria multisysteminflammatorysyndromeinchildrenandsarscov2variantsatwoyearambispectivemulticentriccohortstudyincataloniaspain AT martinezmejiasabel multisysteminflammatorysyndromeinchildrenandsarscov2variantsatwoyearambispectivemulticentriccohortstudyincataloniaspain AT ripollfrancesc multisysteminflammatorysyndromeinchildrenandsarscov2variantsatwoyearambispectivemulticentriccohortstudyincataloniaspain AT lopeznuria multisysteminflammatorysyndromeinchildrenandsarscov2variantsatwoyearambispectivemulticentriccohortstudyincataloniaspain AT contiromina multisysteminflammatorysyndromeinchildrenandsarscov2variantsatwoyearambispectivemulticentriccohortstudyincataloniaspain AT salacastellvipere multisysteminflammatorysyndromeinchildrenandsarscov2variantsatwoyearambispectivemulticentriccohortstudyincataloniaspain AT ruizmontserrat multisysteminflammatorysyndromeinchildrenandsarscov2variantsatwoyearambispectivemulticentriccohortstudyincataloniaspain AT briosonia multisysteminflammatorysyndromeinchildrenandsarscov2variantsatwoyearambispectivemulticentriccohortstudyincataloniaspain AT garcialorenzomarc multisysteminflammatorysyndromeinchildrenandsarscov2variantsatwoyearambispectivemulticentriccohortstudyincataloniaspain AT estellermaria multisysteminflammatorysyndromeinchildrenandsarscov2variantsatwoyearambispectivemulticentriccohortstudyincataloniaspain AT carrerasabadclara multisysteminflammatorysyndromeinchildrenandsarscov2variantsatwoyearambispectivemulticentriccohortstudyincataloniaspain AT herrerohernandocarlos multisysteminflammatorysyndromeinchildrenandsarscov2variantsatwoyearambispectivemulticentriccohortstudyincataloniaspain AT schneiderstephanotto multisysteminflammatorysyndromeinchildrenandsarscov2variantsatwoyearambispectivemulticentriccohortstudyincataloniaspain AT gatellanna multisysteminflammatorysyndromeinchildrenandsarscov2variantsatwoyearambispectivemulticentriccohortstudyincataloniaspain AT aguilarisabel multisysteminflammatorysyndromeinchildrenandsarscov2variantsatwoyearambispectivemulticentriccohortstudyincataloniaspain AT canterojavier multisysteminflammatorysyndromeinchildrenandsarscov2variantsatwoyearambispectivemulticentriccohortstudyincataloniaspain AT ruizgloria multisysteminflammatorysyndromeinchildrenandsarscov2variantsatwoyearambispectivemulticentriccohortstudyincataloniaspain AT fenollosateresa multisysteminflammatorysyndromeinchildrenandsarscov2variantsatwoyearambispectivemulticentriccohortstudyincataloniaspain AT lobatozulema multisysteminflammatorysyndromeinchildrenandsarscov2variantsatwoyearambispectivemulticentriccohortstudyincataloniaspain AT villalobospilar multisysteminflammatorysyndromeinchildrenandsarscov2variantsatwoyearambispectivemulticentriccohortstudyincataloniaspain AT moraemiliano multisysteminflammatorysyndromeinchildrenandsarscov2variantsatwoyearambispectivemulticentriccohortstudyincataloniaspain AT antonjordi multisysteminflammatorysyndromeinchildrenandsarscov2variantsatwoyearambispectivemulticentriccohortstudyincataloniaspain AT visarenenuria multisysteminflammatorysyndromeinchildrenandsarscov2variantsatwoyearambispectivemulticentriccohortstudyincataloniaspain AT solerpalacinpere multisysteminflammatorysyndromeinchildrenandsarscov2variantsatwoyearambispectivemulticentriccohortstudyincataloniaspain AT calaviaolga multisysteminflammatorysyndromeinchildrenandsarscov2variantsatwoyearambispectivemulticentriccohortstudyincataloniaspain AT esquirolherrerocristina multisysteminflammatorysyndromeinchildrenandsarscov2variantsatwoyearambispectivemulticentriccohortstudyincataloniaspain AT guarchibanezborja multisysteminflammatorysyndromeinchildrenandsarscov2variantsatwoyearambispectivemulticentriccohortstudyincataloniaspain AT garciagarciajuanjose multisysteminflammatorysyndromeinchildrenandsarscov2variantsatwoyearambispectivemulticentriccohortstudyincataloniaspain AT comaermengol multisysteminflammatorysyndromeinchildrenandsarscov2variantsatwoyearambispectivemulticentriccohortstudyincataloniaspain AT finafrancesc multisysteminflammatorysyndromeinchildrenandsarscov2variantsatwoyearambispectivemulticentriccohortstudyincataloniaspain AT pratsclara multisysteminflammatorysyndromeinchildrenandsarscov2variantsatwoyearambispectivemulticentriccohortstudyincataloniaspain AT sorianoarandesantoni multisysteminflammatorysyndromeinchildrenandsarscov2variantsatwoyearambispectivemulticentriccohortstudyincataloniaspain |